2024 annual financial data
Amneal Pharmaceuticals 2024 Revenue growth
Direct answer
Revenue growth was 16.73%.
Operating income was 249,326,000 USD and net income was -116,886,000 USD.
Operating cash flow was 295,099,000 USD.
Get free Amneal Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,793,957,000 USD
- Operating income
- 249,326,000 USD
- Net income
- -116,886,000 USD
- Operating cash flow
- 295,099,000 USD